Estimated Global Distribution and Regional Spread of HIV‐1 Genetic Subtypes in the Year 2000

@article{Osmanov2002EstimatedGD,
  title={Estimated Global Distribution and Regional Spread of HIV‐1 Genetic Subtypes in the Year 2000},
  author={S. Osmanov and C. Pattou and N. Walker and Bernhard Schwardl{\"a}nder and J. Esparza},
  journal={JAIDS Journal of Acquired Immune Deficiency Syndromes},
  year={2002},
  volume={29},
  pages={184–190}
}
&NA; The objective of this study was to estimate the global distribution and regional spread of different HIV‐1 genetic subtypes and circulating recombinant forms (CRFs) in the year 2000. These estimates were made based on data derived from global HIV/AIDS surveillance and molecular virology studies. HIV‐1 incidence during the year 2000 was estimated in defined geographic regions, using a country‐specific model developed by WHO‐UNAIDS. The proportion of new infections caused by different HIV‐1… Expand
View on Wolters Kluwer
ncbi.nlm.nih.gov
355 Citations
Highly Influential Citations
14
Background Citations
78
Methods Citations
4
Results Citations
1

Paper Mentions

Interventional Clinical Trial
Phase I Study of HIV Adenoviral Vector Vaccine in Healthy Subjects Using Needle or Biojector Injection
This study will compare the immune response and side effects of an experimental HIV vaccine given by two different methods of administration by needle injection or by use of a… Expand
ConditionsHIV Infections
InterventionDrug
National Institutes of Health Clinical Center (CC)
June 2008 - May 2014
Interventional Clinical Trial
Phase I Study of Vaccination Schedule of Experimental HIV Vaccines
This study will test whether a vaccination schedule of experimental HIV vaccines is safe and whether it causes side effects in healthy adult volunteers. It will also compare the effects… Expand
ConditionsHIV Infections
InterventionDrug
National Institutes of Health Clinical Center (CC)
April 2006 - December 2009
Interventional Clinical Trial
Safety of and Immune Response to an HIV-1 DNA Vaccine (VRC HIVDNA009-00-VP) in HIV Uninfected Adults
The purpose of this study is to test the safety of and immune response to an HIV-1 vaccine, VRC-HIVDNA009-00-VP, in HIV uninfected participants. Two different doses of the vaccine will… Expand
ConditionsHIV Infections
InterventionBiological
National Institute of Allergy and Infectious Diseases (NIAID)
December 2003 - October 2005

355 Citations

Citation Type

Citation Type

Global and regional distribution of HIV-1 genetic subtypes and recombinants in 2004
  • 612
Molecular epidemiology of HIV‐1 subtypes based on analysis of pol sequences in Slovenia, 1996–2005
  • 18
Comparative population dynamics of HIV-1 subtypes B and C: subtype-specific differences in patterns of epidemic growth.
  • 82
  • Highly Influenced
  • PDF
Molecular epidemiology of HIV.
  • 92
Molecular epidemiology of HIV-1 in the United Kingdom
Genetic and phylogenetic evolution of HIV-1 in a low subtype heterogeneity epidemic: the Italian example
  • 22
High genetic diversity of HIV-1 viruses in Macao, China.
  • 5
HIV-1 subtype B: Traces of a pandemic.
  • 33
Epidemiologic and Molecular Characterization of Human Immunodeficiency Virus Type 1 in Southern Brazil
  • 73
Predictions of Future HIV Infection by Subtype and Circulating Recombinant Form
  • 2003
  • 2
  • PDF
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 11 REFERENCES
Country-specific estimates and models of HIV and AIDS: methods and limitations.
  • 98
  • PDF
Phylogenetic analysis of gag genes from 70 international HIV‐1 isolates provides evidence for multiple genotypes
  • 354
Full genome sequences of human immunodeficiency virus type 1 subtypes G and A/G intersubtype recombinants.
  • 240
Genetic relationships determined by a DNA heteroduplex mobility assay: analysis of HIV-1 env genes.
  • 774
Recovery of virtually full-length HIV-1 provirus of diverse subtypes from primary virus cultures using the polymerase chain reaction.
  • 168
Simplified strategy for detection of recombinant human immunodeficiency virus type 1 group M isolates by gag/env heteroduplex mobility assay. Study Group on Heterogeneity of HIV Epidemics in African Cities.
  • 175
  • PDF
Multiple sites in HIV-1 reverse transcriptase associated with virological response to combination therapy
  • 140
  • PDF
HIV-1 Nomenclature Proposal
  • 910
Unequal human immunodeficiency virus type 1 reverse transcriptase error rates with RNA and DNA templates.
  • 136
  • PDF
What role does HIV-1 subtype play in transmission and pathogenesis? An epidemiological perspective.
  • 99
...
1
2
...